CD4 and metabolic dysfunction-associated steatohepatitis: These observations indicated that a single transfer of cDNT to HFD-fed mice could reduce hepatic inflammation, and NASH development by decreasing hepatic CD4+ T cell proportion and survival, and Th17 cell differentiation.